Avoid common mistakes on your manuscript.
Correction: Metabolic Brain Disease.
The original version of this article was revised. The table below shows the incorrect and correct columns.
Page No. Section Paragraph No. Line No. | Incorrect | Correct |
|---|---|---|
Page 1 Author group Line 9 | Susan J. van Rensburg | Susan J. van Rensburg 0000–0002–2437-8978 |
Page 3 Genetic studies Line 13 | Realtime | Real-time |
Page 3 Case descriptions Case 1 Line 1 | RR-MS | RRMS |
Page 6 MRI findings Right hand column | Figure 1 shows MRI Axial T2 FLAIR with multiple hyperintense periventricular white matter lesions of Case 1 (1A) and 2 (1D) respectively, confirming diagnosis of MS. MRI 3D T1 axial and T1 mid sagittal corpus callosum thickness measurements were employed to evaluate brain volumes. Preserved sulcal proportions, gyral volume (1B) and corpus callosum thickness (1C) was noted in Case 1, 15 years after MS diagnosis. In contrast, case 2 exhibited severe sulcal dilatation, reduction of gyral volume (1E) and diffuse thinning of the corpus callosum (1F) supportive of severe reduction in brain volume, 13 years after MS diagnosis. At the time of the brain volume measurements, Case 1 had an EDSS of 2.0, while the EDSS of Case 2 was 6.5. 1C and 1F show sagittal MRI images of the corpus callosum thickness in Case 1 and Case 2 respectively. | Figure 1 shows MRI Axial T2 FLAIR with multiple hyperintense periventricular white matter lesions of Case 1 (a) and 2 (d) respectively, confirming diagnosis of MS. MRI 3D T1 axial and T1 mid sagittal corpus callosum thickness measurements were employed to evaluate brain volumes. Preserved sulcal proportions, gyral volume (b) and corpus callosum thickness (c) was noted in Case 1, 15 years after MS diagnosis. In contrast, case 2 exhibited severe sulcal dilatation, reduction of gyral volume (e) and diffuse thinning of the corpus callosum (f) supportive of severe reduction in brain volume, 13 years after MS diagnosis. At the time of the brain volume measurements, Case 1 had an EDSS of 2.0, while the EDSS of Case 2 was 6.5. Images c and f show sagittal MRI’s of the corpus callosum thickness in Case 1 and Case 2 respectively. |
Page 9 Right hand column Line 89 | range. | range |
Page 10 Left hand column Lines 51 | levels | absorption |
Page 11 Declarations Lines 10–11 | Publication fees for Open Access are supported by the University of Stellenbosch, South Africa | Should be removed |
Page 11 Acknowledgements Lines 3–6 | We acknowledge The South African BioDesign Initiative of the Department of Science and Innovation, South Africa and Winetech, Cape Town, South Africa for research funding | Should be removed |
Author information
Authors and Affiliations
Corresponding author
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
The online version of the original article can be found at https://doi.org/10.1007/s11011-021-00712-9
Rights and permissions
About this article
Cite this article
van Rensburg, S.J., Hattingh, C., Johannes, C. et al. Correction to: Pathology-supported genetic testing as a method for disability prevention in multiple sclerosis (MS). Part II. Insights from two MS cases. Metab Brain Dis 36, 1183–1184 (2021). https://doi.org/10.1007/s11011-021-00722-7
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11011-021-00722-7